A First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System
Not Applicable
- Conditions
- Single Coronary Vessel Disease
- First Posted Date
- 2018-08-06
- Last Posted Date
- 2018-08-06
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 15
- Registration Number
- NCT03616132
- Locations
- 🇲🇾
Institut Jantung Negara, Kuala Lumpur, Negeri Selangor, Malaysia
🇲🇾University Malaya Medical Centre, Kuala Lumpur, Negeri Selangor, Malaysia
Safety and Efficacy Study of Absnow Absorbable ASD Closure System For Treating ASD Patients
Not Applicable
- Conditions
- Atrial Septal DefectHeart Septal Defects, Atrial
- Interventions
- Device: Absnow Absorbable ASD Closure System
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2018-07-26
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 144
- Registration Number
- NCT03601039
- Locations
- 🇨🇳
Kong Xiangqing, Nanjing, Jiangsu, China
🇨🇳Gong Fangqi, Hangzhou, Zhejiang, China
🇨🇳Pan Xiangbin, Beijing, Beijing, China
A First-in-Man Study of IBS
Not Applicable
Active, not recruiting
- Conditions
- Single Coronary Vessel Disease
- Interventions
- Device: Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System
- First Posted Date
- 2018-04-26
- Last Posted Date
- 2021-09-16
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT03509142
- Locations
- 🇨🇳
Beijing Fuwai hospital, Peking, China
Clinical Investigation of the LAmbre Left Atrial Appendage Closure System
Not Applicable
Completed
- Conditions
- Atrial Fibrillation
- Interventions
- Device: LAA closure system
- First Posted Date
- 2017-04-20
- Last Posted Date
- 2017-04-21
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 61
- Registration Number
- NCT03122028
Post Market Clinical Follow-up Study of IrisFITTM PFO (Patent Foramen Ovale) Occluder
Not Applicable
Completed
- Conditions
- Patent Foramen Ovale
- Interventions
- Device: IrisFIT PFO Occluder
- First Posted Date
- 2016-08-30
- Last Posted Date
- 2018-08-09
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 85
- Registration Number
- NCT02882815
- Locations
- 🇩🇪
Cardio Vasculäres Centrum Frankfurt, Frankfurt, Germany
🇩🇪Helmut-G.-Walther-Klinikum, Lichtenfels, Germany
🇮🇪Mater Misericordiae University Hospital, Dublin, Ireland
Lifetech CeraFlex™ Post-Market Surveillance Study
Not Applicable
Completed
- Conditions
- Atrial Septal DefectPatent Foramen OvalePatent Ductus Arteriosus
- Interventions
- Device: CeraFlex
- First Posted Date
- 2015-12-03
- Last Posted Date
- 2020-03-13
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 120
- Registration Number
- NCT02621528
- Locations
- 🇩🇪
Herzzentrum Leipzig GmbH, Leipzig, Germany
🇩🇪Deutsches Herzzentrum München, Munich, Germany
🇩🇪Deutsches Herzzentrum Berlin, Berlin, Germany
Safety and Efficacy Study of LAmbre LAA Closure Device for Treating AF Patients Who Cannot Take Warfarin
Phase 3
- Conditions
- Atrial Fibrillation
- Interventions
- Device: LAA closure system
- First Posted Date
- 2014-01-07
- Last Posted Date
- 2014-03-18
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 154
- Registration Number
- NCT02029014
- Locations
- 🇨🇳
People's Hospital of Wuhan University, Wuhan, Hubei, China
Feasibility and Safety Study of LAmbre Left Atrial Appendage Occluder
Early Phase 1
Completed
- Conditions
- Atrial FibrillationStroke
- Interventions
- Device: LAmbre Left Atrial Appendage(LAA) Occluder
- First Posted Date
- 2013-08-12
- Last Posted Date
- 2018-08-07
- Lead Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT01920412
- Locations
- 🇨🇳
Prince of Wales Hospital, Hong Kong, China
© Copyright 2025. All Rights Reserved by MedPath